VentriPoint Diagnostics Ltd (VPT) - Cash Flow Conversion Efficiency
Based on the latest financial reports, VentriPoint Diagnostics Ltd (VPT) has a cash flow conversion efficiency ratio of 0.146x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-599.37K ≈ $-433.58K USD) by net assets (CA$-4.12 Million ≈ $-2.98 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of VentriPoint Diagnostics Ltd for the company's overall valuation and market capitalisation.
VentriPoint Diagnostics Ltd - Cash Flow Conversion Efficiency Trend (2005–2025)
This chart illustrates how VentriPoint Diagnostics Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
VentriPoint Diagnostics Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of VentriPoint Diagnostics Ltd ranked by their cash flow conversion efficiency. Explore VPT cash to earnings ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
BioLineRx Ltd
NASDAQ:BLRX
|
-0.196x |
|
Libet S.A.
WAR:LBT
|
-0.036x |
|
Great Northern Minerals Ltd
AU:GNM
|
-0.073x |
|
FASING SA
WAR:FSG
|
0.009x |
|
Sebata Holdings Ltd
JSE:SEB
|
0.031x |
|
Reach Resources Ltd
AU:RR1
|
-0.032x |
|
Xenora Minerals Ltd
AU:XRA
|
-0.038x |
|
Natural Alternatives International
NASDAQ:NAII
|
-0.094x |
Annual Cash Flow Conversion Efficiency for VentriPoint Diagnostics Ltd (2005–2025)
The table below shows the annual cash flow conversion efficiency of VentriPoint Diagnostics Ltd from 2005 to 2025. View current stock price of VentriPoint Diagnostics Ltd for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CA$-4.12 Million ≈ $-2.98 Million |
CA$-1.55 Million ≈ $-1.12 Million |
0.378x | -66.74% |
| 2024-12-31 | CA$-2.98 Million ≈ $-2.16 Million |
CA$-3.39 Million ≈ $-2.45 Million |
1.136x | +105.66% |
| 2023-12-31 | CA$189.71K ≈ $137.23K |
CA$-3.80 Million ≈ $-2.75 Million |
-20.052x | -2107.17% |
| 2022-12-31 | CA$4.55 Million ≈ $3.29 Million |
CA$-4.14 Million ≈ $-2.99 Million |
-0.908x | -140.60% |
| 2021-12-31 | CA$8.33 Million ≈ $6.03 Million |
CA$-3.15 Million ≈ $-2.28 Million |
-0.378x | -180.59% |
| 2020-12-31 | CA$-2.35 Million ≈ $-1.70 Million |
CA$-1.10 Million ≈ $-795.98K |
0.469x | -51.41% |
| 2019-12-31 | CA$-2.47 Million ≈ $-1.79 Million |
CA$-2.38 Million ≈ $-1.72 Million |
0.964x | -69.22% |
| 2018-12-31 | CA$-973.26K ≈ $-704.04K |
CA$-3.05 Million ≈ $-2.21 Million |
3.133x | +65.95% |
| 2017-12-31 | CA$-1.63 Million ≈ $-1.18 Million |
CA$-3.07 Million ≈ $-2.22 Million |
1.888x | +93.11% |
| 2016-12-31 | CA$-2.25 Million ≈ $-1.63 Million |
CA$-2.20 Million ≈ $-1.59 Million |
0.978x | -83.62% |
| 2015-12-31 | CA$-269.66K ≈ $-195.07K |
CA$-1.61 Million ≈ $-1.16 Million |
5.967x | +1033.35% |
| 2014-12-31 | CA$-2.40 Million ≈ $-1.73 Million |
CA$-1.26 Million ≈ $-912.31K |
0.526x | -36.40% |
| 2013-12-31 | CA$-3.12 Million ≈ $-2.26 Million |
CA$-2.58 Million ≈ $-1.87 Million |
0.828x | -49.84% |
| 2012-12-31 | CA$-2.65 Million ≈ $-1.92 Million |
CA$-4.37 Million ≈ $-3.16 Million |
1.650x | -3.38% |
| 2011-12-31 | CA$-2.33 Million ≈ $-1.68 Million |
CA$-3.98 Million ≈ $-2.88 Million |
1.708x | -27.65% |
| 2010-12-31 | CA$-860.17K ≈ $-622.24K |
CA$-2.03 Million ≈ $-1.47 Million |
2.360x | +434.52% |
| 2009-12-31 | CA$-3.26 Million ≈ $-2.36 Million |
CA$-1.44 Million ≈ $-1.04 Million |
0.442x | -80.32% |
| 2008-12-31 | CA$-1.87 Million ≈ $-1.35 Million |
CA$-4.20 Million ≈ $-3.04 Million |
2.244x | +682.50% |
| 2007-12-31 | CA$2.50 Million ≈ $1.81 Million |
CA$-965.08K ≈ $-698.12K |
-0.385x | -590.65% |
| 2006-12-31 | CA$670.44K ≈ $484.98K |
CA$-37.40K ≈ $-27.06K |
-0.056x | -886.77% |
| 2005-12-31 | CA$695.36K ≈ $503.01K |
CA$-3.93K ≈ $-2.84K |
-0.006x | -- |
About VentriPoint Diagnostics Ltd
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System (VMS), which transforms standard 2D and 3D echocardiography and a medical imaging system that is used to generate three-dimensional models with critical volume and functional m… Read more